Lancet Oncology Submission Process

Stage 1: Format compliance

The Lancet system checks:

• Structured abstract (Background, Methods, Findings, Interpretation)
• Research in Context panel (Evidence before / Added value / Implications)
• Word count within limits (~5,000 for original research)
• CONSORT/STROBE diagram if applicable
• ICMJE competing interests forms
• Data sharing statement
• Trial registration number (for clinical trials)

Missing any required element delays the submission. The format check is automated but thorough.

Stage 2: Editorial triage

This is where most submissions end. The senior editor reads the Research in Context panel first, then the abstract, then scans the methods and results. The question at this stage is simple: does this evidence change clinical oncology practice?

The editor isn't evaluating the science in detail yet. They're evaluating the claim against the evidence level. A strong biological finding with theoretical clinical implications is desk-rejected. A practice-changing trial with clear results moves forward.

If the editor is unsure, they may consult with a specialty editor or the statistical team before making the desk decision. This is why some desk decisions take 2-3 weeks instead of 1.

Stage 3: Concurrent review

What makes the Lancet family process distinctive: peer review and statistical review happen simultaneously, not sequentially.

Peer reviewers (typically 2-3 clinical oncologists) evaluate:

• Clinical significance of the finding
• Appropriateness of the treatment comparison
• Relevance to global oncology practice
• Quality of the clinical endpoints

In-house statisticians evaluate:

• Randomization and allocation concealment
• Primary endpoint analysis (intention-to-treat)
• Sample size justification
• Subgroup analysis validity
• Multiplicity adjustments
• Missing data handling

The first decision incorporates both tracks. This means the revision request, when it comes, is comprehensive. You won't get statistical critiques as a surprise in the second round.

Stage 4: Revision

Lancet Oncology revisions tend to have tighter timelines than some journals (4-6 weeks typical). The expectation is that the data already exists. The journal rarely asks for new experiments or additional data collection because the study should be complete before submission.

The revision must address:

• Each reviewer comment with a point-by-point response
• Statistical concerns with updated analyses if requested
• Research in Context panel updates if the interpretation changed
• Any new data that emerged during the review period (for ongoing trials)

If the editors see oncology merit but not Lancet Oncology-level importance, they may offer to redirect the paper. Common destinations:

• eClinicalMedicine: Broad clinical medicine with lower selectivity
• Lancet Regional Health journals: If the finding has strong regional but not global relevance
• The Lancet itself: Rare, but some oncology papers have broader medical significance

The redirect often includes the editor's notes, which can speed up review at the receiving journal.

Submit if:

• you have practice-changing clinical oncology evidence (phase III trial, large prospective study)
• the Research in Context panel writes itself because the clinical implications are clear
• the finding has global relevance for oncologists, not just one healthcare system

Think twice if:

• the paper is cancer biology without clinical endpoints (Cancer Cell, Nature Cancer)
• JCO's broader scope and higher publication volume is a more practical target
• the trial is early-phase without definitive evidence of practice change

How long does Lancet Oncology take to make a desk decision?

Typically 1-2 weeks. Some desk decisions take 2-3 weeks if the editor consults with specialty editors or statisticians.

What happens if Lancet Oncology offers a redirect?

The paper is transferred within the Lancet family with the editor's notes. This often speeds up review at the receiving journal. Take the offer seriously.

Does Lancet Oncology accept supplementary appendices?

Yes, and they're expected for trials. The supplementary appendix should include the full statistical analysis plan, protocol, and additional data tables.

How strict is the word limit?

Strictly enforced. ~5,000 words for original research. Longer papers need to justify the length.